107.521 articles found

12492 Clinical Resolution Of Parkinsonism And Dementia Following Radio Frequency Ablation Of A Parathyroid Adenoma

Check source for author details

Journal of the Endocrine Society · 2024-10-05

Role of alpha-synuclein seed amplification assay in Parkinson's disease clinical trials: A case of misdiagnosis.

Tharp E, Martinez-Lemus JD, Schiess MC, Ellmore TM, Suescun J, Shahnawaz M.

Clin Park Relat Disord · 2024-10-05

DOI: 10.1016/j.prdoa.2024.100274PMID: 39963592

MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.

Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O.

NPJ Parkinsons Dis · 2024-10-05

DOI: 10.1038/s41531-024-00791-2PMID: 39369002

Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor.

Mendonça MD, Ferreira P, Barbosa R, da Silva JA.

Neurobiol Dis · 2024-10-05

DOI: 10.1016/j.nbd.2024.106691PMID: 39370052

Cerebrospinal Fluid Total, Phosphorylated and Oligomeric A-Synuclein in Parkinson's Disease: A Systematic Review, Meta-Analysis and Meta-Regression Study.

Kapsali I, Brinia ME, Constantinides VC.

Biomedicines · 2024-10-05

DOI: 10.3390/biomedicines12102266PMID: 39457579

Identification of electromyographic patterns of bradykinesia in patients with Parkinson's disease.

Kozulin N, Migulina A, Mokrushin D, Soghoyan G, Artemenko A, Biktimirov A.

Heliyon · 2024-10-05

DOI: 10.1016/j.heliyon.2024.e39014PMID: 39640647

Changes in fatigue of Parkinson's disease during the recurrent COVID-19 pandemic: Findings from the longitudinal analysis of the PHASE study.

Kataoka H, Saeki K, Tai Y, Nanaura H, Kiriyama T, Sugie K, Obayashi K.

Parkinsonism Relat Disord · 2024-10-05

DOI: 10.1016/j.parkreldis.2024.107161PMID: 39393315

Recognition and characterising non-motor profile in early onset Parkinson's disease (EOPD).

Poplawska-Domaszewicz K, Qamar MA, Falup Pecurariu C, Chaudhuri KR.

Parkinsonism Relat Disord · 2024-10-05

DOI: 10.1016/j.parkreldis.2024.107123PMID: 39489627

Effects of dopaminergic neuron degeneration on osteocyte apoptosis and osteogenic markers in 6-OHDA male rat model of Parkinson's disease.

Knani L, Venditti M, Rouis H, Minucci S, Messaoudi I.

Bone · 2024-10-05

DOI: 10.1016/j.bone.2024.117271PMID: 39369834

Influence of Aerobic Exercise on Functional Capacity and Maximal Oxygen Uptake in Patients With Parkinson Disease: A Systematic Review and Meta-analysis.

Barbieri RA, Barbieri FA, Zelada-Astudillo N, Moreno VC, Kalva-Filho CA, Zamunér AR.

Arch Phys Med Rehabil · 2024-10-05

DOI: 10.1016/j.apmr.2024.09.013PMID: 39374688

Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access program.

Vij R, Kim H, Park H, Cheng T, Lotfi D, Chang D.

Cytotherapy · 2024-10-05

DOI: 10.1016/j.jcyt.2024.09.004PMID: 39425736

Sanggenol L alleviates Rotenone-induced Parkinson’s disease inhibits mitochondrial complex I by apoptotic via P13K/AKT/mTOR signalling

Zhao N, Wu M, Zhang J.

· 2024-10-04

DOI: 10.21203/rs.3.rs-5016013/v1